Posts

Showing posts with the label Osteochondromas market forecast

Osteochondromas – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Osteochondroma can manifest as a singular abnormal growth or as part of multiple osteochondromas in individuals with multiple hereditary exostoses (HME). Its symptoms include a painless protrusion near the joints, pain experienced during physical activity, sensations of numbness or tingling, and alterations in blood flow. Solitary osteochondromas can be categorized into primary and secondary forms based on their causes. Primary osteochondromas develop spontaneously without any identifiable triggering event. In contrast, secondary osteochondromas can arise from childhood exposure to radiation or trauma (such as surgery or Salter-Harris fractures). The prevalence of post-radiation osteochondromas ranges from 6% to 24%, making them the most common benign tumors induced by radiation. The period between radiation exposure and the development of osteochondromas can range from 3 to 17 years. In patients with HME, surgical intervention is more frequently required due to an increased ri...

Osteochondromas – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
Osteochondroma can manifest as a singular abnormal growth or as part of multiple osteochondromas in individuals with multiple hereditary exostoses (HME). Its symptoms include a painless protrusion near the joints, pain experienced during physical activity, sensations of numbness or tingling, and alterations in blood flow. Solitary osteochondromas can be categorized into primary and secondary forms based on their causes. Primary osteochondromas develop spontaneously without any identifiable triggering event. In contrast, secondary osteochondromas can arise from childhood exposure to radiation or trauma (such as surgery or Salter-Harris fractures). The prevalence of post-radiation osteochondromas ranges from 6% to 24%, making them the most common benign tumors induced by radiation. The period between radiation exposure and the development of osteochondromas can range from 3 to 17 years. In patients with HME, surgical intervention is more frequently required due to an increased risk of ma...